EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 151 filers reported holding EPIZYME INC in Q3 2020. The put-call ratio across all filers is 2.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $317,000 | -94.9% | 61,853 | -91.7% | 0.00% | -100.0% |
Q2 2021 | $6,198,000 | -16.9% | 745,749 | -12.8% | 0.00% | 0.0% |
Q1 2021 | $7,462,000 | -24.9% | 855,346 | -6.5% | 0.00% | -50.0% |
Q4 2020 | $9,940,000 | -12.1% | 915,115 | -3.4% | 0.00% | -20.0% |
Q3 2020 | $11,307,000 | -27.6% | 947,804 | -2.6% | 0.01% | -28.6% |
Q2 2020 | $15,624,000 | -3.6% | 972,815 | -6.9% | 0.01% | -12.5% |
Q1 2020 | $16,207,000 | -37.4% | 1,044,838 | -0.7% | 0.01% | -11.1% |
Q4 2019 | $25,890,000 | +199.2% | 1,052,593 | +25.5% | 0.01% | +200.0% |
Q3 2019 | $8,654,000 | -2.3% | 838,991 | +18.9% | 0.00% | 0.0% |
Q2 2019 | $8,856,000 | +29.0% | 705,683 | +27.4% | 0.00% | 0.0% |
Q1 2019 | $6,863,000 | +100.3% | 553,937 | -0.4% | 0.00% | +50.0% |
Q4 2018 | $3,427,000 | +35.2% | 556,341 | +132.6% | 0.00% | +100.0% |
Q3 2018 | $2,535,000 | +126.7% | 239,184 | +266.9% | 0.00% | 0.0% |
Q1 2017 | $1,118,000 | +128.6% | 65,194 | +61.4% | 0.00% | – |
Q4 2016 | $489,000 | +44.2% | 40,387 | +17.2% | 0.00% | – |
Q3 2016 | $339,000 | – | 34,468 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |